{"id":"https://openalex.org/W2167069168","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2217","title":"Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers","display_name":"Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers","publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W2167069168","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2217","mag":"2167069168","pmid":"https://pubmed.ncbi.nlm.nih.gov/16533787"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-05-2217","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2217","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2217","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050269562","display_name":"Gregory Paul Adams","orcid":"https://orcid.org/0000-0003-4207-2881","observed_orcids":["https://orcid.org/0000-0003-4207-2881"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory P. Adams","raw_affiliation_strings":["1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113489879","display_name":"Mei-Sheng Tai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mei-Sheng Tai","raw_affiliation_strings":["2Creative BioMolecules, Hopkinton, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Creative BioMolecules, Hopkinton, Massachusetts;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042945151","display_name":"John E. McCartney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John E. McCartney","raw_affiliation_strings":["2Creative BioMolecules, Hopkinton, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Creative BioMolecules, Hopkinton, Massachusetts;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038349275","display_name":"James D. Marks","orcid":"https://orcid.org/0000-0003-0562-3517","observed_orcids":["https://orcid.org/0000-0003-0562-3517"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D. Marks","raw_affiliation_strings":["5Department of Anesthesiology, University of California, San Francisco, California; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Anesthesiology, University of California, San Francisco, California; and","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041909668","display_name":"Walter F. Stafford","orcid":"https://orcid.org/0000-0003-0004-9341","observed_orcids":["https://orcid.org/0000-0003-0004-9341"]},"institutions":[{"id":"https://openalex.org/I1309400984","display_name":"Boston Biomedical Research Institute","ror":"https://ror.org/04rqpth59","country_code":"US","type":"facility","lineage":["https://openalex.org/I1309400984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Walter F. Stafford","raw_affiliation_strings":["4Boston Biomedical Research Institute, Watertown, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Boston Biomedical Research Institute, Watertown, Massachusetts;","institution_ids":["https://openalex.org/I1309400984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112776971","display_name":"L. L. Houston","orcid":"https://orcid.org/0009-0002-9825-2304","observed_orcids":["https://orcid.org/0009-0002-9825-2304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L.L. Houston","raw_affiliation_strings":["6Chiron Corporation, Emeryville, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Chiron Corporation, Emeryville, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054562347","display_name":"James S. Huston","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James S. Huston","raw_affiliation_strings":["2Creative BioMolecules, Hopkinton, Massachusetts;","3EMD Lexigen Research Center, Billerica, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Creative BioMolecules, Hopkinton, Massachusetts;","institution_ids":[]},{"raw_affiliation_string":"3EMD Lexigen Research Center, Billerica, Massachusetts;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045107557","display_name":"Louis M. Weiner","orcid":"https://orcid.org/0000-0001-5192-0710","observed_orcids":["https://orcid.org/0000-0001-5192-0710"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis M. Weiner","raw_affiliation_strings":["1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.6414,"has_fulltext":false,"cited_by_count":100,"citation_normalized_percentile":{"value":0.98943296,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"12","issue":"5","first_page":"1599","last_page":"1605"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.06809999793767929,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.9049999713897705},{"id":"https://openalex.org/keywords/avidity","display_name":"avidity","score":0.6359999775886536},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.890999972820282},{"id":"https://openalex.org/keywords/tumor-retention","display_name":"tumor retention","score":0.9549999833106995},{"id":"https://openalex.org/keywords/valence","display_name":"valence","score":0.5789999961853027},{"id":"https://openalex.org/keywords/molecular-weight","display_name":"molecular weight","score":0.906000018119812},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.7599999904632568},{"id":"https://openalex.org/keywords/radiolabeled-antibodies","display_name":"radiolabeled antibodies","score":0.6869999766349792},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":0.546999990940094},{"id":"https://openalex.org/keywords/disulfide-bonds","display_name":"disulfide bonds","score":0.515999972820282},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.5139999985694885},{"id":"https://openalex.org/keywords/scid-mice","display_name":"SCID mice","score":0.45899999141693115},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6100000143051147},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.5239999890327454},{"id":"https://openalex.org/keywords/iodine-125-labeling","display_name":"iodine-125 labeling","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C179223381","wikidata":"https://www.wikidata.org/wiki/Q419425","display_name":"Avidity","level":3,"score":0.7865946292877197},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6288337707519531},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5556850433349609},{"id":"https://openalex.org/C2779546866","wikidata":"https://www.wikidata.org/wiki/Q531306","display_name":"Dimer","level":2,"score":0.4784029424190521},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.46017730236053467},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3480048179626465},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3325885236263275},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32252079248428345},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2752145826816559},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11083903908729553},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000915","descriptor_name":"Antibody Affinity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000918","descriptor_name":"Antibody Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019281","descriptor_name":"Dimerization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-05-2217","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2217","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2217","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:16533787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16533787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4824609705","display_name":"ENGINEERED ANTIBREAST CANCER SINGLE CHAIN FV IMMUNOTOXIN","funder_award_id":"U01CA051880","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W61795934","https://openalex.org/W187705992","https://openalex.org/W1505534997","https://openalex.org/W1572912927","https://openalex.org/W1807228574","https://openalex.org/W1929634773","https://openalex.org/W1967244419","https://openalex.org/W1982501635","https://openalex.org/W1988384969","https://openalex.org/W2006013401","https://openalex.org/W2007256480","https://openalex.org/W2009179035","https://openalex.org/W2014148382","https://openalex.org/W2019159661","https://openalex.org/W2026378086","https://openalex.org/W2047184374","https://openalex.org/W2050557902","https://openalex.org/W2067465835","https://openalex.org/W2069451410","https://openalex.org/W2075998703","https://openalex.org/W2096214890","https://openalex.org/W2119423559","https://openalex.org/W2134758761","https://openalex.org/W2141393790","https://openalex.org/W2151480508","https://openalex.org/W2151605875","https://openalex.org/W2156037313","https://openalex.org/W2156643886","https://openalex.org/W2161551116","https://openalex.org/W2168948640","https://openalex.org/W2188972723","https://openalex.org/W2462645005","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2026378086","https://openalex.org/W2216991061","https://openalex.org/W2151480508","https://openalex.org/W2014148382","https://openalex.org/W2027269306","https://openalex.org/W1982501635","https://openalex.org/W2031833938","https://openalex.org/W2006013401","https://openalex.org/W1929634773","https://openalex.org/W7098528241"],"abstract_inverted_index":{"Radiolabeled":[0],"single-chain":[1],"Fv":[2],"(sFv)":[3],"molecules":[4,43],"display":[5],"highly":[6],"specific":[7],"tumor":[8,62,133,188,208,211,241],"retention":[9,63,112,189,242],"in":[10,25,61,98,183],"the":[11,19,26,31,37,41,50,89,104,115,175,186,196,239,251,260],"severe":[12],"combined":[13],"immunodeficient":[14],"(SCID)":[15],"mouse":[16],"model;":[17],"however,":[18],"absolute":[20],"quantity":[21],"of":[22,40,49,67,106,118,135,178,190,195,243,253,264],"sFv":[23,42,52,73,150,153,161,232,247],"retained":[24],"tumors":[27,99],"is":[28],"diminished":[29],"by":[30,47,79],"rapid":[32],"renal":[33],"elimination":[34],"resulting":[35],"from":[36,53,250,259],"small":[38],"size":[39,117],"(Mr":[44,146],"27,000)":[45],"and":[46,109,148,159,165,210,230],"dissociation":[48],"monovalent":[51,72,142],"tumor-associated":[54],"antigen.":[55],"We":[56],"previously":[57],"reported":[58],"significant":[59],"improvement":[60],"without":[64],"a":[65,80],"loss":[66],"targeting":[68,134],"specificity":[69,156,162],"on":[70],"converting":[71],"into":[74,88],"divalent":[75,136],"[(sFv')2]":[76,121],"dimers,":[77],"linked":[78],"disulfide":[81],"bond":[82],"between":[83,103],"COOH-terminal":[84],"cysteinyl":[85],"peptides":[86],"engineered":[87],"sFv'.":[90],"However,":[91],"our":[92],"data":[93],"for":[94,157,163,185,221],"enhanced":[95,107],"dimer":[96],"localization":[97,212],"could":[100],"not":[101],"distinguish":[102,174],"contributions":[105],"avidity":[108],"increased":[110],"systemic":[111,262],"associated":[113],"with":[114,141],"larger":[116],"54":[119],"kDa":[120],"dimers":[122],"relative":[123],"to":[124,173,202],"27-kDa":[125],"sFv.":[126],"In":[127],"this":[128],"investigation,":[129],"we":[130],"have":[131],"compared":[132],"anti-c-erbB-2/HER2/neu":[137],"741F8-1":[138,191],"(sFv')2":[139,144,192,223,227,244],"homodimers":[140,245],"741F8/26-10":[143],"heterodimers":[145],"54,000)":[147],"741F8":[149],"monomers":[151,248],"(741F8":[152],"has":[154],"binding":[155,255],"erbB-2/HER2/neu":[158],"26-10":[160],"digoxin":[164],"related":[166],"cardiac":[167],"glycosides).":[168],"These":[169,235],"studies":[170],"allowed":[171],"us":[172],"dominant":[176],"effect":[177],"valency":[179],"over":[180,246],"molecular":[181],"weight":[182],"accounting":[184],"superior":[187],"homodimers.":[193,265],"Each":[194],"radioiodinated":[197],"species":[198],"was":[199,219],"administered":[200],"i.v.":[201,217],"SCID":[203],"mice":[204],"bearing":[205],"SK-OV-3":[206],"human":[207],"xenografts":[209],"at":[213],"24":[214],"hours":[215],"post":[216],"injection":[218],"determined":[220],"125I-741F8-1":[222,231],"(3.57":[224],"%ID/g),":[225,229],"125I-741F8/26-10":[226],"(1.13":[228],"(1.25":[233],"%ID/g).":[234],"findings":[236],"substantiate":[237],"that":[238],"improved":[240],"results":[249],"availability":[252],"dual":[254],"sites":[256],"rather":[257],"than":[258],"slower":[261],"clearance":[263]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}